TNXP TONIX PHARMACEUTICALS HLDG C

Ownership history in Engineers Gate Manager LP  ·  2 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in TONIX PHARMACEUTICALS HLDG C (TNXP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 14,263 +5,550 +63.7% 0.00% $223K $15.62
2025 Q3 INITIATED 8,713 0.00% $211K $24.16
% of Fund (quarterly)    TNXP price (monthly, adj. close)
← Back to Engineers Gate Manager LP Holdings